Altimmune (ALT, $8.01) was a top loser yesterday, declining to $8.01 per share. Of the 903 stocks analyzed in the Biotechnology Industry, of them () exhibited an Uptrend while of them () were in a Downtrend. 7 similar cases when ALT's price dropped within one day were found. In out of those 7 cases, ALT's price went down during the subsequent month. Based on these historical data, the odds of a Downtrend continuation for ALT are